Literature DB >> 34674019

Differential expression of miRNA in histological subtype of Wilms tumor.

Disha Kakkar1, Saumyaranjan Mallick1, Aijaz Ahmad1, Ansh Goswami1, Sandeep Agarwala2, Aditya Kumar Gupta3, V Sreenivas4, Sameer Bakhshi5, K Devasenathipathy6, Sandeep Mathur1, Deepali Jain1, Rachana Seth3, Venkateswaran K Iyer7.   

Abstract

INTRODUCTION: Wilms tumor is the most common renal malignancy in children and difficult to differentiate from other paediatric abdominal tumors radiologically, necessitating an invasive procedure for diagnosis. Previous studies have shown the potential role of miRNA as biomarkers for diagnosis, histological subtyping and prognosis. In this study, we are exploring the role of miRNA in the histological subtyping of Wilms tumor in the Indian population.
MATERIALS AND METHODS: A total of 15 cases of Wilms tumor were evaluated for global miRNA expression analysis by microarray. Total RNA was extracted from fresh frozen tumor and miRNA expression analysis was performed using Agilent platform. Unsupervised clustering was done to analyse the data.
RESULTS: Using unpaired student T test, top 10 significantly differentially expressed miRNA were selected which could differentiate among different histological subtypes by unsupervised hierarchical clustering and principal component analysis. The presence of necrosis, heterologous differentiation led to change in miRNA expression profile and led to a distinct cluster formation.
CONCLUSIONS: A panel of 5 miRNAs (miR1, 133b, 299-3p, 499a-5p, 491-3p) could differentiate among different histological subtypes of Wilms tumor, thus avoiding an invasive procedure in children, however, further confirmation using real time PCR analysis will be needed.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Histology; Prognosis; Wilms tumor; miRNA expression

Mesh:

Substances:

Year:  2021        PMID: 34674019     DOI: 10.1007/s00383-021-05034-6

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  20 in total

1.  MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4.

Authors:  Xiangqiang Liu; Zhiyong Zhang; Li Sun; Na Chai; Shanhong Tang; Jiang Jin; Hao Hu; Yongzhan Nie; Xin Wang; Kaichun Wu; Haifeng Jin; Daiming Fan
Journal:  Carcinogenesis       Date:  2011-09-20       Impact factor: 4.944

2.  Circulating serum miRNAs as potential biomarkers for nephroblastoma.

Authors:  Nicole Ludwig; Nasenien Nourkami-Tutdibi; Christina Backes; Hans-Peter Lenhof; Norbert Graf; Andreas Keller; Eckart Meese
Journal:  Pediatr Blood Cancer       Date:  2015-03-18       Impact factor: 3.167

3.  Noncoding RNA-related polymorphisms in pediatric acute lymphoblastic leukemia susceptibility.

Authors:  Angela Gutierrez-Camino; Elixabet Lopez-Lopez; Idoia Martin-Guerrero; Maria A Piñan; Purificacion Garcia-Miguel; Jose Sanchez-Toledo; Ana Carbone Bañeres; Javier Uriz; Aurora Navajas; Africa Garcia-Orad
Journal:  Pediatr Res       Date:  2014-03-11       Impact factor: 3.756

4.  MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.

Authors:  Shan Dang; Jian Zhou; Zongyan Wang; Kunning Wang; Shejiao Dai; Shuixiang He
Journal:  Biomed Pharmacother       Date:  2018-07-14       Impact factor: 6.529

5.  miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation.

Authors:  C Denoyelle; B Lambert; M Meryet-Figuière; N Vigneron; E Brotin; C Lecerf; E Abeilard; F Giffard; M-H Louis; P Gauduchon; P Juin; L Poulain
Journal:  Cell Death Dis       Date:  2014-10-09       Impact factor: 8.469

6.  Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers.

Authors:  Xiaoying Zhang; Harriet Gee; Barbara Rose; C Soon Lee; Jonathan Clark; Michael Elliott; Jennifer R Gamble; Murray J Cairns; Adrian Harris; Samantha Khoury; Nham Tran
Journal:  BMC Cancer       Date:  2016-02-11       Impact factor: 4.430

7.  miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer.

Authors:  Ruifang Sun; Zhigang Liu; Dongdong Tong; Yang Yang; Bo Guo; Xiaofei Wang; Lingyu Zhao; Chen Huang
Journal:  Cell Death Dis       Date:  2017-03-30       Impact factor: 8.469

8.  Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes.

Authors:  Nicole Ludwig; Tamara V Werner; Christina Backes; Patrick Trampert; Manfred Gessler; Andreas Keller; Hans-Peter Lenhof; Norbert Graf; Eckart Meese
Journal:  Int J Mol Sci       Date:  2016-03-30       Impact factor: 5.923

9.  miR-133a-3p promotes apoptosis and induces cell cycle arrest by targeting CREB1 in retinoblastoma.

Authors:  Jianchang Li; Xiuming Liu; Wenqi Wang; Chaopeng Li
Journal:  Arch Med Sci       Date:  2019-07-25       Impact factor: 3.318

View more
  1 in total

1.  Evaluation and management of "low" anorectal malformation in male children: an observational study.

Authors:  Gaurav Shandilya; Anand Pandey; Nitin Pant; Gurmeet Singh; Akhilesh Kumar; Jiledar Rawat
Journal:  Pediatr Surg Int       Date:  2021-10-27       Impact factor: 1.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.